SYK Stock Price Today (October 2026) — Stryker Corporation Analysis & Key Metrics 2026-10-20
Stryker Corporation (SYK) is trading at $304.40, up 2.17% today (as of October 2026). The stock continues to show early recovery signs above the short-term average, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $362.62 (19.1% upside).
- Volatility is low (23.71% annualized), implying relatively contained price movements for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (9.40% YoY) alongside competitive pressures in the Medical Devices space.
SYK Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
Stryker Corporation - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $128.73B
P/E Ratio
Forward P/E: 19.33
Revenue Growth
Year over Year
Analyst Target
+19.1% upside potential
Key Investor Questions About SYK
What investors need to know before buying
Based on current market data, SYK presents a overbought technical setup with looking solid fundamentals.
- Technicals say: Overbought (RSI 74.79)
- Fundamentals say: Looking solid (debt and growth supportive)
SYK's growth trajectory depends on its ability to expand within the Medical Devices sector while managing margin pressures.
- Future growth will depend on performance in core Medical Devices operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for SYK investors include debt exposure and competitive dynamics in the Medical Devices industry.
- $15.45B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Medical Devices.
52-Week Trading Range
Over the past year, SYK stock traded between $267.00 and $392.55 and currently trades in the middle of that range. Big swings are less likely unless a major catalyst emerges.
Volatility & Risk Profile
With 23.71% annualized volatility and β=0.32, the stock exhibits low sensitivity to market moves—making SYK suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Intuitive Surgical (ISRG): Does Leasing Make Growth More Durable or More Capital Intensive?
Why ISRG Is Lowering Instrument Costs Despite Strong Profitability
What iShares U.S. Medical Devices ETF (IHI) Sold: Abbott Leads on Friday
ETFs Are Net Sellers of Stryker (SYK) on Friday
Is Stryker Corp. (SYK) Positioned for Above-Market Growth?
Latest TickZen Insights
All insights →No TickZen article on SYK yet. Our newest analysis:
Explore More Analysis for SYK
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
Next report Oct 29, 2026 (after the close)
Frequently Asked Questions
Common investor questions about Stryker Corporation
Stryker Corporation (SYK) is currently trading at $304.40. The RSI (14-day) is at 74.8, indicating overbought territory (potentially overheated). Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $362.62 implies 19.1% upside from current levels. Volatility is moderate at 23.7% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for Stryker Corporation (SYK): The trailing P/E ratio is 29.18, which is in line with broader market averages. The forward P/E is 19.33, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.52, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 4.51. Price-to-Sales is 4.18. Valuation should be compared to Medical Devices industry peers for context, as different sectors trade at different multiples.
Based on 26 analysts covering SYK, the consensus price target is $362.62. This represents a 19.1% upside from the current price of $304.40. The range spans from a low target of $298.00 to a high target of $465.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, Stryker Corporation (SYK) pays a dividend with a current yield of approximately 1.16%. The annualized dividend rate is $3.48 per share. The payout ratio is 36.1%, which is conservative and suggests the dividend is well-covered by earnings with room for future increases. The most recent ex-dividend date was Sep 30, 2026.
Key risks for Stryker Corporation (SYK) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Medical Devices sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is Stryker Corporation's (SYK) current debt and financial health profile: Total debt stands at $15.45B. The debt-to-equity ratio is 0.64x, which is moderate and generally manageable for most companies. The current ratio is 2.16, indicating strong short-term liquidity. The quick ratio is 1.08. The company holds $3.48B in cash and equivalents. Free cash flow is positive at $4.11B, providing a cushion for debt servicing and shareholder returns.